These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31802621)

  • 1. Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights.
    Saladini M; Nizzardo M; Govoni A; Taiana M; Bresolin N; Comi GP; Corti S
    J Cell Mol Med; 2020 Jan; 24(2):1169-1178. PubMed ID: 31802621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.
    Vanoli F; Rinchetti P; Porro F; Parente V; Corti S
    J Cell Mol Med; 2015 Sep; 19(9):2058-66. PubMed ID: 26095024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Perego MGL; Galli N; Nizzardo M; Govoni A; Taiana M; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2020 Sep; 77(17):3351-3367. PubMed ID: 32123965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile spinal muscular atrophy with respiratory distress type I presenting without respiratory involvement: Novel mutations and review of the literature.
    Luan X; Huang X; Liu X; Zhou H; Chen S; Cao L
    Brain Dev; 2016 Aug; 38(7):685-9. PubMed ID: 26922252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells.
    Jędrzejowska M; Madej-Pilarczyk A; Fidziańska A; Mierzewska H; Pronicka E; Obersztyn E; Gos M; Pronicki M; Kmieć T; Migdał M; Mierzewska-Schmidt M; Walczak-Wojtkowska I; Konopka E; Hausmanowa-Petrusewicz I
    Eur J Paediatr Neurol; 2014 Mar; 18(2):183-92. PubMed ID: 24388491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.
    Porro F; Rinchetti P; Magri F; Riboldi G; Nizzardo M; Simone C; Zanetta C; Faravelli I; Corti S
    J Neurol Sci; 2014 Nov; 346(1-2):35-42. PubMed ID: 25248952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing up with spinal muscular atrophy with respiratory distress (SMARD1).
    Hamilton MJ; Longman C; O'Hara A; Kirkpatrick M; McWilliam R
    Neuromuscul Disord; 2015 Feb; 25(2):169-71. PubMed ID: 25454169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Heterogeneity of Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1)-A Report of Three Cases, Including Twins.
    Leśniak A; Glińska M; Patalan M; Ostrowska I; Świrska-Sobolewska M; Giżewska-Kacprzak K; Kotkowiak A; Leśniak A; Walczak M; Śmigiel R; Giżewska M
    Genes (Basel); 2024 Jul; 15(8):. PubMed ID: 39202358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient with spinal muscular atrophy with respiratory distress type 1 presenting initially with hypertonia.
    Han C; Mai J; Tian T; He Y; Liao J; Wen F; Yi X; Yang Y
    Brain Dev; 2015 May; 37(5):542-5. PubMed ID: 25280635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically relevant mouse models of severe spinal muscular atrophy with respiratory distress type 1.
    Holbrook SE; Hicks AN; Martin PB; Hines TJ; Castro HP; Cox GA
    Hum Mol Genet; 2024 Oct; 33(20):1800-1814. PubMed ID: 39128026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Local Translation of β-actin mRNA in Ighmbp2-Deficient Motoneurons: Implications for Spinal Muscular Atrophy with respiratory Distress (SMARD1).
    Surrey V; Zöller C; Lork AA; Moradi M; Balk S; Dombert B; Saal-Bauernschubert L; Briese M; Appenzeller S; Fischer U; Jablonka S
    Neuroscience; 2018 Aug; 386():24-40. PubMed ID: 29928949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.
    Shababi M; Feng Z; Villalon E; Sibigtroth CM; Osman EY; Miller MR; Williams-Simon PA; Lombardi A; Sass TH; Atkinson AK; Garcia ML; Ko CP; Lorson CL
    Mol Ther; 2016 May; 24(5):855-66. PubMed ID: 26860981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An atypical phenotype of a patient with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD 1).
    Wu S; Chen T; Li Y; Chen L; Xu Q; Xiao F; Bai Z
    Eur J Med Genet; 2018 Oct; 61(10):602-606. PubMed ID: 29653221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral nerve pathology at fixed stage in spinal muscular atrophy with respiratory distress type 1.
    Ikeda A; Yamashita S; Tsuyusaki Y; Tanaka M; Tanaka Y; Hashiguchi A; Takashima H; Goto T
    Brain Dev; 2018 Feb; 40(2):155-158. PubMed ID: 28899595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal muscular atrophy with respiratory distress type 1: A multicenter retrospective study.
    Viguier A; Lauwers-Cances V; Cintas P; Manel V; Peudenier S; Desguerre I; Quijano-Roy S; Vanhulle C; Fradin M; Isapof A; Jokic M; Mathieu-Dramard M; Dieterich K; Petit F; Magdelaine C; Giuliano F; Gras D; Haye D; Nizon M; Magen M; Bieth E; Cances C
    Neuromuscul Disord; 2019 Feb; 29(2):114-126. PubMed ID: 30598237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Genome Sequencing and RNA Analysis Reveals and Characterizes a Deep Intronic Variant in IGHMBP2 in a Patient With Spinal Muscular Atrophy With Respiratory Distress Type 1.
    Bodle EE; Zhu W; Velez-Bartolomei F; Tesi-Rocha A; Liu P; Bernstein JA
    Pediatr Neurol; 2021 Jan; 114():16-20. PubMed ID: 33189025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
    Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Diers A; Kaczinski M; Grohmann K; Hübner C; Stoltenburg-Didinger G
    Acta Neuropathol; 2005 Sep; 110(3):289-97. PubMed ID: 16025284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.
    Grohmann K; Schuelke M; Diers A; Hoffmann K; Lucke B; Adams C; Bertini E; Leonhardt-Horti H; Muntoni F; Ouvrier R; Pfeufer A; Rossi R; Van Maldergem L; Wilmshurst JM; Wienker TF; Sendtner M; Rudnik-Schöneborn S; Zerres K; Hübner C
    Nat Genet; 2001 Sep; 29(1):75-7. PubMed ID: 11528396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy with respiratory distress type 1 (SMARD1): a rare cause of hypotonia, diaphragmatic weakness, and respiratory failure in infants.
    Pekuz S; Güzin Y; Sarıtaş S; Kırbıyık Ö; Ünalp A; Yılmaz Ü
    Turk J Pediatr; 2022; 64(2):364-374. PubMed ID: 35611426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.